Sunshine Biopharma
SBFM
6 hedge funds and large institutions have $152K invested in Sunshine Biopharma in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
146% more capital invested
Capital invested by funds: $61.8K → $152K (+$90K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.19% more ownership
Funds ownership: 0.1% → 0.29% (+0.19%)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$127K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$47.8K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
+$11.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$34K |
| 2 |
Morgan Stanley
New York
|
-$9.58K |
| 3 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$12 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
Altium Capital Management
New York
| $96.4K | +$127K | +5,047 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $38K | +$47.8K | +1,902 | +2,186% |
|
|
SS
3
SBI Securities
Tokyo,
Japan
| $9.98K | +$11.3K | +451 | +635% |
|
|
4
Morgan Stanley
New York
| $7.32K | -$9.58K | -381 | -50% |
|
5
National Bank of Canada
Montreal,
Quebec, Canada
| $19 | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $10 | – | – | – |
|
|
FFA
7
Farther Finance Advisors
San Francisco,
California
| $2 | – | – | – |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2 | – | – | – |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $2 | – | – | – |
|
|
RA
10
Rise Advisors
Rochester,
New York
| $2 | – | – | – |
|
|
TWC
11
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $2 | – | – | – |
|
|
CCM
12
Connective Capital Management
Palo Alto,
California
| – | -$34K | -1,135 | Closed |
|
|
13
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$12 | – | – |
|
SBFM Hedge Fund Activity: Q1 2025 in Review
6 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q1 2025, worth a combined $152K — up 146% from $61.8K a quarter earlier.
Fund positioning in SBFM was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $127K. The largest seller was Connective Capital Management, exiting entirely with an estimated $34K sold.
- 6 institutional investors held Sunshine Biopharma (SBFM) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $152K of Sunshine Biopharma stock for Q1 2025, up 146% quarter-over-quarter.
- 1 fund opened new Sunshine Biopharma positions in Q1 2025 and 1 closed out, a net change of 0 holders.
- The largest Sunshine Biopharma buyer in Q1 2025 was Altium Capital Management, an estimated $127K added.
- The largest Sunshine Biopharma seller in Q1 2025 was Connective Capital Management, an estimated $34K sold.
Based on aggregated 13F filings for Q1 2025.